Cell MedX Corp (CMXC)
Stock Price: $0.3000 USD
0.0000 (0.00%)
Updated Jan 13, 2021 3:44 PM EST - Market closed
| Market Cap | 17.22M |
| Revenue (ttm) | 68,624 |
| Net Income (ttm) | -934,461 |
| Shares Out | 59.39M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 13 |
| Last Price | $0.3000 |
| Previous Close | $0.3000 |
| Change ($) | 0.0000 |
| Change (%) | 0.00% |
| Day's Open | 0.3000 |
| Day's Range | 0.2801 - 0.3050 |
| Day's Volume | 164,529 |
| 52-Week Range | 0.2 - 0.799 |
News
There are no news available yet.
About CMXC
Cell MedX, a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general relaxation and for the temporary relief of pain due to sore and/or aching muscles. The company was formerly known as Sports Asylum, Inc. and... [Read more...]
| Industry Diagnostics & Research | |
| CEO Frank Edward McEnulty | Country United States |
| Stock Exchange OTCMKTS | Ticker Symbol CMXC |